Nachrichten zur Illumina Inc. Aktie

Illumina wins partial victory as proxy firm ISS backs CEO DeSouza

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Glass Lewis Withholds Support for Illumina CEO in Icahn Win

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina Unusual Options Activity

read more...…

Glass Lewis backs Carl Icahn attempt to replace Illumina CEO and chair

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina Requests Shareholders To Vote For All Nine Of Its Director Nominees

SAN DIEGO (dpa-AFX) - Illumina (ILMN) issued a shareholder letter highlighting the strength of its Board. The company also noted…

Illumina-Aktie: „Barbar“ Carl Icahn wütet – Kaufchance?

Die Illumina-Aktie (WKN: 927079) hat seit Mitte 2021 eine schlechte Performance abgeliefert. Sie hat sich gegenüber dem damaligen Kurs mehr…

Better Gene Sequencing Stock: Illumina vs. Bionano Genomics

This is a classic matchup of a grizzled top dog against a scrappy competitor....…

Why Illumina Fell 11.6% in April

The gene-sequencing company reported weaker results while the Federal Trade Commission has ordered it to divest its Grail acquisition....…

Form 10-Q ILLUMINA, INC. For: Apr 02

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina: Icahn’s nominees ‘unqualified’

Illumina Inc. ILMN said Monday that activist investor Carl Icahn’s board nominees are “unqualified,” urging shareholders to reject all three…

Medizin-Geräte: Warnung vor kritischer Sicherheitslücke in Illumina-Software

Die US-IT-Sicherheitsbehörde CISA warnt vor kritischen Sicherheitslücken in den medizinischen Geräten von Illumina. Angreifer könnten die Kontrolle übernehmen....…

Illumina DNA sequencing devices could be vulnerable to hackers - FDA

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Critical-rated security flaw in Illumina DNA sequencing tech exposes patient data

The U.S. government has sounded the alarm about a critical software vulnerability found in genomics giant Illumina’s DNA sequencing devices,…

Illumina: Breeding Better Sugar With Genomics

Originally published on Illumina News CenterNORTHAMPTON, MA / ACCESSWIRE / April 27, 2023 / Folk wisdom says that putting sugar…

Illumina (ILMN) Q1 Earnings Beat Estimates, Margins Contract

Illuminas (ILMN) Q1 revenues decline year over year, reflecting the impact of Covid-19 monitoring headwinds and the transition of its…

Illumina (ILMN) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Illumina (ILMN) give a sense of how the business performed in the quarter…

Illumina (ILMN) Beats Q1 Earnings and Revenue Estimates

Illumina (ILMN) delivered earnings and revenue surprises of 300% and 2.42%, respectively, for the quarter ended March 2023. Do the…

Illumina unveils $100M annual cost cutting plan

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina unveils plans to cut costs as it faces shrinking margins

The plans aim to reduce Illuminas annualized run rate expenses by more than $100 million starting later this year....…

Illumina Now Expects to Post Per-Share Loss in FY23

Illumina Now Expects to Post Per-Share Loss in FY23...…

Illumina Inc. Q1 Profit Decreases, but beats estimates

SAN DIEGO (dpa-AFX) - Illumina Inc. (ILMN) revealed a profit for first quarter that decreased from last year but beat…

Illumina 1Q Profit, Revenue Drops

Illumina 1Q Profit, Revenue Drops...…

Illumina Non-GAAP EPS of $0.08 beats by $0.05, revenue of $1.09B beats by $20M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina Reports Financial Results for First Quarter of Fiscal Year 2023; Announces Commitment to Accelerate Margin Growth

Revenue of $1.09 billion for Q1 2023, up 1% from Q4 2022; down 11% from Q1 2022 (down 9% on…

Illumina: Sequencing at Sea - Unlocking the Power of the Genome With eDNA and NextSeq 2000

NORTHAMPTON, MA / ACCESSWIRE / April 24, 2023 / In 2022, Illumina and Minderoo Foundation announced a $40M AUD partnership…

Illumina under the spotlight as Q1 earnings approach

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina wins fast-track appeal of FTC order to offload Grail

...By Mike Scarcella (Reuters) - A U.S. appeals court on Tuesday......…

Freedom Finance Börsenfrühstück - "Milliardenmarkt Krebsforschung und Krebstherapie"

Es sind erschreckende Zahlen: Eine halbe Million Menschen erkrankt in Deutschland jedes Jahr an Krebs. Meist beginnt damit ein Leidensweg…

Illumina Celebrates "Save the Smile of the Yangtze River" Charity Walk in China

NORTHAMPTON, MA / ACCESSWIRE / April 18, 2023 / Illumina:From March 23rd to March 29th, a total of 206 Illumina…

Ravgen settles patent fight with Illumina over genetic testing

...By Blake Brittain (Reuters) - Gene-sequencing giant Illumina Inc......…

Illumina: The African Continent Ramps Up Efforts To Crack the Code on Outbreaks

NORTHAMPTON, MA / ACCESSWIRE / April 17, 2023 / IlluminaSamuel Oyola, senior scientist and head of genomics at Nairobis International…

Illumina: Fail with GRAIL

Das Drama um die Illumina-Ausgründung GRAIL hat den Aktienkurs zu Fall gebracht. Der aktivistische Investor Carl Icahn erhöht den Druck.…

Illumina (ILMN) Partners With Henry Ford Health for NGS Test

Illumina (ILMN) collaborates with Henry Ford Health to conduct a series of studies that is likely to focus on the…

Local Teachers Spread Passion for STEM with SD2/Illumina Corporate Foundation STEM Educators Award

NORTHAMPTON, MA / ACCESSWIRE / April 11, 2023 / IlluminaOriginally published on SD2By Allison HardenThe 2022 SD2 and Illumina Corporate…

Illumina, Henry Ford Health partner to study impact of genomic testing in heart disease

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Is There Any Hope for Illumina Stock?

Being in trouble with regulators in two major markets sure wont help anything....…

Illumina Rings the Bell at Nasdaq

NORTHAMPTON, MA / ACCESSWIRE / April 6, 2023 / IlluminaOriginally published on Illumina News CenterThe Nasdaq closing bell in New…

Carl Icahn calls for removal of Illumina CEO Francis deSouza

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina to Announce First Quarter 2023 Financial Results on Tuesday, April 25, 2023

SAN DIEGO, April 4, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) announced today that it will issue results for the first…

25 Greatest Impacts in 25 Years: Illumina and the Evolution of Genomics

NORTHAMPTON, MA / ACCESSWIRE / April 4, 2023 / IlluminaOriginally published on Illumina News CenterThis month, Illumina celebrates a quarter…

FTC Overturns Approval of $7 Billion Illumina-Grail Deal

Its probably too late to put the champagne back in the bottle. Some six months after biotech giant Illumina gained…

FTC Orders Illumina To Divest Cancer Test Developer Grail

SAN DIEGO (dpa-AFX) - The Federal Trade Commission on Monday ordered Illumina Inc. (ILMN) to divest its acquisition of cancer…

Illumina: US FTC weist das US-Unternehmen an, die Übernahme von Grail rückgängig zu machen - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Illumina-Aktienanalyse von "Der Aktionär": Jan Paul Fóri vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Illumina Inc. (ISIN:…

Illumina: US-Behörde setzt Aktie unter Druck – die Details

Schlechte Nachricht für Illumina. Die US-Behörde Federal Trade Commission (FTC) hat das US-Unternehmen angewiesen, die Übernahme von Grail rückgängig zu…

F.T.C. Orders Gene-Sequencing Company Illumina to Divest Acquisition

The move by the commission is seen as a test of regulators efforts to prevent big companies from buying small…

U.S. Orders Illumina to Divest Cancer Tester Grail

Chief Executive Francis deSouza had championed the deal to get Illumina into the nascent market for blood tests that can…

Illumina prepared to divest GRAIL if FTC appeal fails

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

FTC orders Illumina to divest Grail; Illumina plans to appeal

The Federal Trade Commission on Monday ordered Illumina Inc. ILMN to divest Grail Inc., saying that “the deal would stifle…

US FTC orders Illumina to divest cancer detection test maker Grail

...By Diane Bartz WASHINGTON (Reuters) - The U.S. Federal Trade......…

FTC orders Illumina to divest $7.1 billion acquisition of cancer test developer Grail

The decision reverses an administrative judges ruling that dismissed the FTCs initial challenge of Illuminas $7.1 billion Grail deal....…